- Home
- MVBF vs ABEO Comparison
MVBF vs ABEO Comparison
Compare MVBF & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MVBF | ABEO |
|---|---|---|
| Founded | 1997 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 338.1M | 312.6M |
| IPO Year | 2004 | 2005 |
Fundamental Metrics
Financial Performance| Metric | MVBF | ABEO |
|---|---|---|
| Price | $25.77 | $5.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $29.50 | $20.00 |
| AVG Volume (30 Days) | 23.1K | ★ 1.0M |
| Earning Date | 04-29-2026 | 05-14-2026 |
| Dividend Yield | ★ 2.62% | N/A |
| EPS Growth | 34.64 | ★ 165.16 |
| EPS | ★ 2.06 | 1.01 |
| Revenue | ★ $3,400,000.00 | $2,998,000.00 |
| Revenue This Year | $1.70 | $1,024.31 |
| Revenue Next Year | $13.59 | $145.42 |
| P/E Ratio | $12.66 | ★ $5.45 |
| Revenue Growth | 51.92 | ★ 258.18 |
| 52 Week Low | $16.45 | $4.00 |
| 52 Week High | $29.59 | $7.54 |
Technical Indicators
Market Signals| Indicator | MVBF | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 48.77 | 58.61 |
| Support Level | $25.30 | $5.24 |
| Resistance Level | $26.14 | $5.62 |
| Average True Range (ATR) | 0.54 | 0.24 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 30.85 | 68.15 |
Price Performance
Historical ComparisonAbout MVBF MVB Financial Corp.
MVB Financial Corp is a financial holding company. The company provides a wide range of business activities through the Bank, commercial and retail banking services, as well as Fintech banking. It has three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of its revenue is generated from the CoRe Banking segment, which includes its Fintech division, represents banking products and services offered to customers by the Bank, loans and deposits accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.